S1E68 - Why MedTech Needs More Than Approval with Michael Branagan Harris of HealthTech Strategies Limited

A device can clear regulatory hurdles and still struggle commercially if the evidence is too narrow. MedTech companies need proof that speaks to affordability, care quality, operational impact, and long term value, not just technical performance.

Market selection matters just as much. The same solution may fit the United States, the UK, Germany, or the Netherlands very differently because reimbursement models, provider incentives, and care delivery systems are not built the same way.

Episode Breakdown

00:00 Opening

09:02 What evidence actually needs to prove

14:16 Building a stronger adoption case

22:43...